Close Menu

NEW YORK (GenomeWeb News) – Investment bank Goldman Sachs today upgraded shares of Quest Diagnostics and Laboratory Corporation of America, but downgraded Sigma-Aldrich.

In a research note, analyst Isaac Ro upgraded Quest to Buy from Neutral and LabCorp to Neutral from Sell. He downgraded Sigma-Aldrich to Sell from Neutral.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.